Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Sun Fights US Charges Over Delays

Indian Firm Pushes Back Against Charges Of Delaying Market Entry

Dec 06 2019

• By Penelope MacRae

Sun_Pharma_Magnified — Sun is contesting US antitrust charges revolving around delayed market entry • Source: Shutterstock

Related Content

Ex-Sun Employee Alleges Reprisal For Opposing US Off-Label Practices

Nov 13 2019

US modafinil charge devastates Sun profit

Nov 23 2018

Sun's China, Japan Plans Gather Pace

Nov 11 2019

Related Companies

Sun Pharmaceutical Industries Ltd.

Additional Topics

United States Legal Issues Launches Generic Drugs BioPharmaceutical

More from Legal & IP

More from Generics Bulletin

Twitter feed RSS feed RSS feed

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window

Copyright © 2025 Pharma Intelligence UK Limited (Citeline), a Norstella company Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered.